This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Transvaginal Mesh Lawsuit Update: Plaintiff's Closing Argument Stresses Proof That J&J Ignored Info About Prolift's Dangers, Rottenstein Law Group Reports

ATLANTIC CITY, N.J., Feb. 16, 2013 /PRNewswire/ -- As part of the closing arguments he delivered at the trial of a vaginal mesh lawsuit in New Jersey Superior Court today, the attorneys for plaintiff Linda Gross, 47, showed the jury e-mails and re-played videotaped deposition testimony showing Ethicon's repeated decisions to ignore reports of complications related to its Prolift vaginal mesh in a rush to get that mesh to market, the Rottenstein Law Group reports.


Gross' attorney illustrated that executives at medical device manufacturer Ethicon repeatedly ignored the concerns of at least one doctor about the safety of the company's Prolift vaginal mesh kit by showing the jury copies of the executives' e-mails. In those e-mails, Ethicon executives stated that: (1) They respected the doctor's opinion; and (2) Should get back to the doctor in the interest of understanding his concerns. The executives nevertheless failed to follow up with the doctor properly, Gross' attorney said. This is the first of 1,800 vaginal mesh lawsuits against Ethicon pending in New Jersey Superior Court to go to trial.

Among the other evidence that Gross' attorney presented again to the jury during his closing argument was the testimony of Scott Ciarrocca, an Ethicon executive, which stated that Ethicon executives were motivated to get the Prolift to market as soon as possible in order to beat the launch of AMS mesh, a product created by one of Ethicon's competitors.

"We're relieved that one of the Prolift cases has gone to trial," said Rochelle Rottenstein, principal of the Rottenstein Law Group, which represents women in vaginal mesh lawsuits. "We look forward to helping other women who've been seriously harmed by vaginal mesh products get compensation for their injuries."

The Rottenstein Law Group maintains a website that describes all of the issues vaginal mesh patients face and explains their options. You may visit the website here. A free informational brochure about the process of preparing a lawsuit is available for download.

About the Rottenstein Law GroupThe Rottenstein Law Group is a New York-based law firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action lawsuits. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:The Rottenstein Law Group, LLP Rochelle Rottenstein, Esq.321 W. 44th Street# 804 New York NY 10036(212) 933-9500 (office phone)(212) 933-9980 (facsimile)rochelle (at) rotlaw (dot) com

SOURCE The Rottenstein Law Group

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs